Use of LXR agonists for the treatment of osteoarthritis

Details for Australian Patent Application No. 2007297721 (hide)

Owner Wyeth

Inventors Nagpal, Sunil; Collins-Racie, Lisa; Yang, Zhiyong; Lavallie, Edward; Morris, Elisabeth

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2007297721

PCT Pub. Number WO2008/036239

Priority 60/845,576 19.09.06 US

Filing date 18 September 2007

Wipo publication date 27 March 2008

International Classifications

A61K 31/00 (2006.01)

A61K 31/18 (2006.01) - Sulfonamides

A61K 31/195 (2006.01)

A61K 31/404 (2006.01)

A61K 31/42 (2006.01) - Oxazoles

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61K 31/575 (2006.01) - substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol

A61K 31/58 (2006.01) - containing heterocyclic rings, e.g. aldosterone, danazol, stanozolol, pancuronium, digitogenin

A61P 19/02 (2006.01) Drugs for skeletal disorders

G01N 33/74 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving hormones

G01N 33/92 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving lipids, e.g. cholesterol

Event Publications

9 April 2009 PCT application entered the National Phase

  PCT publication WO2008/036239 Priority application(s): WO2008/036239

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007297723-Membrane separation process for removing residuals from polyamineepihalohydrin resins

2007297716-Solid unit dose, sweetening compositions